Found 5 matching trials
Phase 3 Study of MAP0004 in Adult Migraineurs
PHASE3This is a randomized, double blind, placebo controlled, parallel group stud...
Location
Swedish Pain and Headache Clinic
Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers
PHASE1Compare the pharmacokinetics of Dihydroergotamine Mesylate (DHE) delivered ...
Location
Simbec Research Limited
Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure
PHASE1Compare the acute effects and tolerability of Dihydroergotamine Mesylate (D...
Location
Duke Clinical Research Unit
Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole
PHASE1Compare the DHE pharmacokinetic profiles observed following administration ...
Location
Simbec Research Limited
QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo
PHASE1Compare the acute effect on the QT interval of MAP0004 (Dihydroergotamine M...